As of 2025-05-29, the Fair Value of Qualigen Therapeutics Inc (QLGN) is -53.07 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.74 USD, the upside of Qualigen Therapeutics Inc is -1,518.85%.
With the market price of 3.74 USD and our fair value calculation, Qualigen Therapeutics Inc (QLGN) is not a good investment. Investing in QLGN stocks now will result in a potential loss of 1,518.85%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -10.13 | -19.55 | -17.90 | -18.64 | -13.42 | -15.93 |
| YoY growth | 39.95% | -92.99% | 8.44% | -4.13% | 28.02% | -4.14% |
| Market Cap (mil) | 2.77 |
| P/E | |
| Forward P/E |
| EPS | -10.61 |
| Avg earnings growth rate | -4.14% |
| TTM earnings | -7.85 |